Reports
Bridging the Gap: Transforming EU Biotech Policy
Date
October 13, 2024
Why is Europe lagging behind the US in biotech innovation? Discover new analysis and actionable reforms with the potential to unlock €15 billion, create jobs, and bring breakthrough medicines to patients faster.
Overview
ADC and Dansk Bio’s new report reveals what’s holding EU biotech back, and how targeted policy change can close the gap with the US. Key findings span funding shortfalls, translation challenges, and regulatory bottlenecks.
Three main challenges
- Funding shortfall: EU pension funds invest 100x less than US peers, costing billions in growth.
- Translation gap: Europe’s top research often fails to scale commercially.
- Regulatory delay: Clinical and drug approvals take up to 40% longer than in the US.
The path forward
The report identifies three transformative policy interventions:
- Align pension fund rules with the...
Date
October 13, 2024
Why is Europe lagging behind the US in biotech innovation? Discover new analysis and actionable reforms with the potential to unlock €15 billion, create jobs, and bring breakthrough medicines to patients faster.
Overview
ADC and Dansk Bio’s new report reveals what’s holding EU biotech back, and how targeted policy change can close the gap with the US. Key findings span funding shortfalls, translation challenges, and regulatory bottlenecks.
Three main challenges
- Funding shortfall: EU pension funds invest 100x less than US peers, costing billions in growth.
- Translation gap: Europe’s top research often fails to scale commercially.
- Regulatory delay: Clinical and drug approvals take up to 40% longer than in the US.
The path forward
The report identifies three transformative policy interventions:
- Align pension fund rules with the...
Enter your email to gain access
Gain full access to limited free articles, news alerts, select newsletters, and stay up to date with all other ADC insights.